The 2023 chemotherapy shortage led to a 60% drop in cisplatin use for head and neck cancer, with costly substitutes increasing treatment expenses. The shortage was exacerbated by the FDA's shutdown of ...
The high prices of chemotherapy drugs and the financial burden they pose on public programs, private insurers and patients is a major source of concern. However, addressing this problem through ...
Hospitals’ chemotherapy drug prices are often marked up two to 10 times the cost, according to a Charlotte Observer report. The Charlotte Observer and The News & Observer of Raleigh investigated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results